Search research articles
Contact Us
Filters
Showing results (181-190 of 242) with videos related to
Page
of 25
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1992
Treatment of malignant mesothelioma with epirubicin and ifosfamide: a phase II cooperative study
M D Magri, S Foladore, A Veronesi, et al.
Clinical Chemistry
|
May 1, 1990
High predictivity of galactosyl-hydroxylysine in urine as an indicator of bone metastases from breast cancer
L Moro, C Gazzarrini, C Modricky, et al.
Cancer Detection and Prevention
|
January 1, 1990
Characterization of AIDS-associated tumors in Italy: report of 435 cases of an IVDA-based series
S Monfardini, E Vaccher, A Lazzarin, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1986
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tract
A Veronesi, E Galligioni, G Lo Re, et al.
Blood
|
December 15, 1995
The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias
A Carbone, A Gloghini, V Zagonel, et al.
Cancer Treatment Reviews
|
October 1, 1994
Lung cancer in the elderly
V Zagonel, A Pinto, D Serraino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survival
D Errante, V Zagonel, E Vaccher, et al.
Tumori
|
September 1, 1974
[Adriamycin in combination and in combined treatment modalities (author's transl)]
G Bonadonna, G Beretta, G Tancini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Adjuvant chemotherapy for elderly patients (> or =70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients
A Brunello, U Basso, C Pogliani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot study
S Frustaci, A Buonadonna, E Galligioni, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 242) with videos related to
Sort By:
Page
of 25
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1992
Treatment of malignant mesothelioma with epirubicin and ifosfamide: a phase II cooperative study
M D Magri, S Foladore, A Veronesi, et al.
Clinical Chemistry
|
May 1, 1990
High predictivity of galactosyl-hydroxylysine in urine as an indicator of bone metastases from breast cancer
L Moro, C Gazzarrini, C Modricky, et al.
Cancer Detection and Prevention
|
January 1, 1990
Characterization of AIDS-associated tumors in Italy: report of 435 cases of an IVDA-based series
S Monfardini, E Vaccher, A Lazzarin, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1986
Combination chemotherapy with fluorouracil, adriamycin, cis-platinum and VM-26 in advanced transitional cell carcinoma of the urinary tract
A Veronesi, E Galligioni, G Lo Re, et al.
Blood
|
December 15, 1995
The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias
A Carbone, A Gloghini, V Zagonel, et al.
Cancer Treatment Reviews
|
October 1, 1994
Lung cancer in the elderly
V Zagonel, A Pinto, D Serraino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survival
D Errante, V Zagonel, E Vaccher, et al.
Tumori
|
September 1, 1974
[Adriamycin in combination and in combined treatment modalities (author's transl)]
G Bonadonna, G Beretta, G Tancini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Adjuvant chemotherapy for elderly patients (> or =70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients
A Brunello, U Basso, C Pogliani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Increasing 4'-epidoxorubicin and fixed ifosfamide doses plus granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a pilot study
S Frustaci, A Buonadonna, E Galligioni, et al.
Page
of 25